The goal of this proposal is to identify cellular genes that are critical for growth or survival of neoplastically transformed cells and to design prototype """"""""genetic drugs"""""""" targeting such genes. The target genes will be identified through the selection of cDNA fragments that inhibit the function of the gene from which they are derived. These fragments are called growth-inhibiting genetic suppressor elements (GSEs). GSEs that have a cytostatic or cytotoxic effect on neoplastically transformed cells will be isolated using inducible retroviral vectors and selection protocols already developed during the previous period of this project. Three types of selections will be carried out. The first selection will use a random fragment library prepared from a mixture of cDNA clones of different human genes implicated in positive regulation of cell growth. This will be used to isolate GSEs that would be inhibitory for a human fibrosarcoma cell line. The second selection will be carried out in a transformed mouse embryo fibroblast (MEF) cell line, using a library of random cDNA fragments from genes that are overexpressed in the transformed line (relative to untransformed MEF). The third selection will utilize a library of random fragments of normalized cDNA corresponding to all genes expressed in the transformed MEF line; this library will be used to isolate GSEs that are specially cytostatic or cytotoxic to neoplastically transformed MEF cells (in relation to the untransformed MEF cells). Full-length human sequences of unknown genes giving rise to the selected GSGs will be cloned and their expression patterns will be characterized. The biological activity of the GSEs isolated through all selection types will be tested on cell lines derived from different types of mouse or human tumors and on normal cells. The most efficient GSEs will be tested in the form of retroviral vectors or chemically synthesized peptides or oligonucleotides. The proposed studies should lead to the identification of new targets and prototype genetic drugs with potential for the treatment of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA062099-05
Application #
2837678
Study Section
Pathology B Study Section (PTHB)
Program Officer
Forry-Schaudies, Suzanne L
Project Start
1994-01-19
Project End
2000-11-30
Budget Start
1998-12-01
Budget End
1999-11-30
Support Year
5
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Genetics
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Shtutman, Michael; Maliyekkel, Anil; Shao, Yu et al. (2010) Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing. Proc Natl Acad Sci U S A 107:7377-82
Chan, Chi Yu; Carmack, C Steven; Long, Dang D et al. (2009) A structural interpretation of the effect of GC-content on efficiency of RNA interference. BMC Bioinformatics 10 Suppl 1:S33
Yates, Kristin E; Korbel, Gregory A; Shtutman, Michael et al. (2008) Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell 7:609-21
Broude, Eugenia V; Demidenko, Zoya N; Vivo, Claire et al. (2007) p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle 6:1468-71
Broude, E V; Swift, M E; Vivo, C et al. (2007) p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation. Oncogene 26:6954-8
Shao, Yu; Chan, Chi Yu; Maliyekkel, Anil et al. (2007) Effect of target secondary structure on RNAi efficiency. RNA 13:1631-40
Barre, Benjamin; Vigneron, Arnaud; Perkins, Neil et al. (2007) The STAT3 oncogene as a predictive marker of drug resistance. Trends Mol Med 13:4-11
Chen, Yuhong; Dokmanovic, Milos; Stein, Wilfred D et al. (2006) Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells. Cancer Res 66:8749-61
Davidovich, Irina A; Levenson, Anait S; Levenson Chernokhvostov, Victor V (2004) Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance. Cancer Lett 211:189-97
Shay, Jerry W; Roninson, Igor B (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23:2919-33

Showing the most recent 10 out of 34 publications